Denmark Sweden Norway Finland

Human FGF-21 (Luc) HEK293 Reporter Cell

Fibroblast growth factor 21 (FGF21), which stimulates glucose uptake in differentiated adipocytes via the induction of glucose transporter SLC2A1/GLUT1 expression. FGF21 has been shown to protect animals from diet-induced obesity when overexpressed in transgenic mice. It also lowers blood glucose and triglyceride levels when administered to diabetic rodents, suggesting it may exhibit the therapeutic characteristics necessary for effective treatment of diabetes. Treatment of animals with FGF21 results in increased energy expenditure, fat utilisation and lipid excretion. FGF21 is most abundantly expressed in the liver, and also expressed in the thymus at lower levels.

Please sign in to see prices
Or contact us directly
Product #: CHEK-ATF163-2Vials-202 Unit size: 1Vial*2 Supplier: ACROBiosystems Available in the following countries:
Denmark Norway Sweden Finland
Got any questions?

Get in touch with one of our specialists

Henrik Tind Nielsen profile picture
Henrik Tind Nielsen CCO & Product Specialist Automation
Cristina Battagli profile picture
Cristina Battagli Product Specialist: Diagnostics, Metabolomics, Imaging & Cell Biology
News and Promotions
Kem-En-Tec Nordic A/S Logo
Kem-En-tec Nordic A/S
 Kuldyssen 10, 2630 Taastrup
 +45 3927 1777
 Parkvägen 12, 448 34 Floda
 +46 18 149000
 info@kem-en-tec-nordic.com
Follow Us
Sign up for our newsletter
Yes, I give permission to store my data